Preradiotherapy MR Imaging: A Prospective Pilot Study of the Usefulness of Performing an MR Examination Shortly before Radiation Therapy in Patients with Glioblastoma

References

1. 1.↵
   2. Ostrom QT,
   3. Gittleman H,
   4. Liao P, et al

   . CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol 2014;16(suppl 4):iv1–63 doi:10.1093/neuonc/nou223 pmid:25304271

   FREE Full Text
2. 2.↵
   2. Weller M,
   3. van den Bent M,
   4. Hopkins K, et al

   . EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol 2014;15:e395–403 doi:10.1016/S1470-2045(14)70011-7 pmid:25079102

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Stupp R,
   3. Mason WP,
   4. van den Bent MJ, et al

   . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96 doi:10.1056/NEJMoa043330 pmid:15758009

   CrossRefPubMedWeb of Science
4. 4.↵
   NCCN Guidelines. NCCN guidelines for treatment of cancer by site. Central Nervous System Cancers. National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#cns. . Updated 2015Accessed December 9, 2015.
5. 5.↵
   2. Albert FK,
   3. Forsting M,
   4. Sartor K, et al

   . Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994;34:45–60; discussion 60–61 doi:10.1227/00006123-199401000-00008 pmid:8121569

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Brandsma D,
   3. Stalpers L,
   4. Taal W, et al

   . Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 2008;9:453–61 doi:10.1016/S1470-2045(08)70125-6 pmid:18452856

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Wen PY,
   3. Macdonald DR,
   4. Reardon DA, et al

   . Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010;28:1963–72 doi:10.1200/JCO.2009.26.3541 pmid:20231676

   Abstract/FREE Full Text
8. 8.↵
   2. Hygino da Cruz LC Jr.,
   3. Rodriguez I,
   4. Domingues RC, et al

   . Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol 2011;32:1978–85 doi:10.3174/ajnr.A2397 pmid:21393407

   Abstract/FREE Full Text
9. 9.↵
   2. Pirzkall A,
   3. McGue C,
   4. Saraswathy S, et al

   . Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. Neuro Oncol 2009;11:842–52 doi:10.1215/15228517-2009-005 pmid:19229057

   Abstract/FREE Full Text
10. 10.↵
    2. Valduvieco I,
    3. Verger E,
    4. Bruna J, et al

    . Impact of radiotherapy delay on survival in glioblastoma. Clin Transl Oncol 2013;15:272–82 doi:10.1007/s12094-012-0916-x pmid:22855197

    CrossRefPubMed
11. 11.↵
    2. Ekinci G,
    3. Akpinar IN,
    4. Baltacioglu F, et al

    . Early-postoperative magnetic resonance imaging in glial tumors: prediction of tumor regrowth and recurrence. Eur J Radiol 2003;45:99–107 doi:10.1016/S0720-048X(02)00027-X pmid:12536087

    CrossRefPubMed
12. 12.↵
    2. Majós C,
    3. Cos M,
    4. Castañer S, et al

    . Early post-operative magnetic resonance imaging in glioblastoma: correlation among radiological findings and overall survival in 60 patients. Eur Radiol 2016;26:1048–55 doi:10.1007/s00330-015-3914-x pmid:26188660

    CrossRefPubMed
13. 13.↵
    2. Essig M,
    3. Anzalone N,
    4. Combs SE, et al

    . MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice. AJNR Am J Neuroradiol 2012;33:803–17 doi:10.3174/ajnr.A2640 pmid:22016411

    Abstract/FREE Full Text
14. 14.↵
    2. Stupp R,
    3. Tonn JC,
    4. Brada M, et al

    . High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21:90–93 doi:10.1093/annonc/mdq187 pmid:20555079

    CrossRefPubMed
15. 15.↵
    2. Gorlia T,
    3. van den Bent MJ,
    4. Hegi ME, et al

    . Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. Lancet Oncol 2008;9:29–38 doi:10.1016/S1470-2045(07)70384-4 pmid:18082451

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Curran WJ Jr.,
    3. Scott CB,
    4. Horton J, et al

    . Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993;85:704–10 doi:10.1093/jnci/85.9.704 pmid:8478956

    Abstract/FREE Full Text
17. 17.↵
    2. Scott CB,
    3. Scarantino C,
    4. Urtasun R, et al

    . Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG90-06. Int J Radiat Oncol Biol Phys 1998;40:51–55 doi:10.1016/S0360-3016(97)00485-9 pmid:9422557

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Allahdini F,
    3. Amirjamshidi A,
    4. Reza-Zarei M, et al

    . Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: does maximal resection of the tumor lengthen the median survival? World Neurosurg 2010;73:128–34 doi:10.1016/j.wneu.2009.06.001 pmid:20860940

    CrossRefPubMedWeb of Science
19. 19.↵
    2. McGirt MJ,
    3. Chaichana KL,
    4. Gathinji M, et al

    . Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 2009;110:156–62 doi:10.3171/2008.4.17536 pmid:18847342

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Lacroix M,
    3. Abi-Said D,
    4. Fourney DR, et al

    . A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95:190–98 doi:10.3171/jns.2001.95.2.0190 pmid:11780887

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Sanai N,
    3. Berger MS

    . Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008;62:753–64; discussion 264–66 doi:10.1227/01.neu.0000318159.21731.cf pmid:18496181

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Smets T,
    3. Lawson TM,
    4. Grandin C, et al

    . Immediate post-operative MRI suggestive of the site and timing of glioblastoma recurrence after gross total resection: a retrospective longitudinal preliminary study. Eur Radiol 2013;23:1467–77 doi:10.1007/s00330-012-2762-1 pmid:23314599

    CrossRefPubMed